An exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 906-908

  Mason, Keira P ^a   Zgleszewski, Steven ^a   Forman, Roberta E ^a   Stark, Cynthia ^a   DiNardo, James A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; DEXMEDETOMIDINE; GLYCOPYRRONIUM BROMIDE; LITHIUM; VASOPRESSIN; CENTRAL DEPRESSANT AGENT; HYPNOTIC SEDATIVE AGENT; OXYGEN;

ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; BRADYCARDIA; BREATHING RATE; CASE REPORT; CHILD; CONTINUOUS INFUSION; DRUG MEGADOSE; DRUG WITHDRAWAL; ENURESIS; HEART RATE; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PEDIATRIC ANESTHESIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEDATION; ADOLESCENT; BLOOD; BRAIN TUMOR; BREATHING MECHANICS; CHEMICALLY INDUCED DISORDER; CONSCIOUS SEDATION; CRANIOFACIAL SYNOSTOSIS; DRUG EFFECT; KLINEFELTER SYNDROME; NEUROFIBROMATOSIS; PATHOPHYSIOLOGY; TUBEROUS SCLEROSIS;

ADJUVANTS, ANESTHESIA; ADOLESCENT; BRADYCARDIA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CONSCIOUS SEDATION; CRANIOSYNOSTOSES; DEXMEDETOMIDINE; GLYCOPYRROLATE; HEART RATE; HUMANS; HYPERTENSION; HYPNOTICS AND SEDATIVES; KLINEFELTER SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 1; OXYGEN; RESPIRATORY MECHANICS; TUBEROUS SCLEROSIS;

EID: 61949147525     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181948a6f     Document Type: Article

References (12)

1. Mason KP, Zgleszewski SE, Dearden JL, Dumont RS, Pirich MA, Stark CD, D'Angelo P, Macpherson S, Fontaine PJ, Connor L, Zurakowski D. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg 2006; 103:57- 62, table of contents
2. Mason KP, Zgleszewski SE, Prescilla R, Fontaine PJ, Zurakowski D. Hemodynamic effects of dexmedetomidine sedation for ct imaging studies. Paediatr Anaesth 2008;18:393-402
3. Mason KP, Zurakowski D, Zgleszewski SE, Robson C, Carrier M, Hickey P, DiNardo JA. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008;18:403-11
4. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974;2:656-9
5. Nelson MD Jr. Guidelines for the monitoring and care of children during and after sedation for imaging studies. AJR Am J Roentgenol 1993;160:581-2
6. Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg 1970;49:924-34
7. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94
8. Hammer GB, Drover DR, Cao H, Jackson E, Williams GD, Ramamoorthy C, Van Hare GF, Niksch A, Dubin AM. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 2008;106:79-83, table of contents
9. Wilkins BW, Hesse C, Sviggum HP, Nicholson WT, Moyer TP, Joyner MJ, Eisenach JH. Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. Clin Auton Res 2007;17:77-84
10. Wilkins BW, Hesse C, Charkoudian N, Nicholson WT, Sviggum HP, Moyer TP, Joyner MJ, Eisenach JH. Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade. Clin Pharmacol Ther 2008;83:692-701
11. Murrell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg 2005;32:117-27
12. Bloor BC, Frankland M, Alper G, Raybould D, Weitz J, Shurtliff M. Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther 1992;263:690-7